SEC Form 4 · accession 0001596771-15-000031
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary W Kadlec
Officer — President · Director
Period of report
Mar 31, 2015
Accepted (ET)
Apr 1, 2015 · 2:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option to Acquire Common StockF2,F1 | $4.28 | Mar 31, 2015 | D | 185,352 | D | — | Sep 1, 2022 | Common Stock | 185,352 | 8,024 | D |
Explanation of responses
- F1The options were granted on 9/1/12 and vest according to certain performance criteria of the company. As of the date hereof, 193,376 of the options had vested in accordance with the performance criteria.
- F2On March 31, 2015, the options designated in column 5 were repurchased by the Issuer. The purchase price for the option repurchase was based on the $29.00 per common share price of the Issuer's March 25, 2015 public offering, net of the underwriting discount ($1.45) and the per share exercise price of the options.